BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7407315)

  • 1. An illness-death model for the study of the carcinogenic process using survival/sacrifice data.
    Kodell RL; Nelson CJ
    Biometrics; 1980 Jun; 36(2):267-77. PubMed ID: 7407315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonparametric joint estimators for disease resistance and survival functions in survival/sacrifice experiments.
    Kodell RL; Shaw GW; Johnson AM
    Biometrics; 1982 Mar; 38(1):43-58. PubMed ID: 7082762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of distributions of time to appearance of tumor and time to death from tumor after appearance in mice fed 2-acetylaminofluorene.
    Kodell RL; Farmer JH; Greenman DL; Frith CH
    J Environ Pathol Toxicol; 1980; 3(3 Spec No):89-102. PubMed ID: 7365388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of cause-of-death assignment on time-to-tumor analyses in animal carcinogenesis studies.
    Kodell RL; Farmer JH; Gaylor DW; Cameron AM
    J Natl Cancer Inst; 1982 Sep; 69(3):659-64. PubMed ID: 7050501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of lag time between onset of and death from an occult tumor.
    Ahn H; Moon H; Kodell RL
    J Biopharm Stat; 2008; 18(5):901-14. PubMed ID: 18781524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semiparametric analysis of tumor incidence rates in survival/sacrifice experiments.
    Portier CJ; Dinse GE
    Biometrics; 1987 Mar; 43(1):107-14. PubMed ID: 3567301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Assessment of the parameters of the growth kinetics of an experimental tumor].
    Kamynina TV; Iakovlev AIu; Klimovich VB
    Eksp Onkol; 1988; 10(2):66-9. PubMed ID: 3391125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonparametric methods for survival/sacrifice experiments.
    Dewanji A; Kalbfleisch JD
    Biometrics; 1986 Jun; 42(2):325-41. PubMed ID: 3741974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genetic and oncological characteristics of CC57BR/Mv mice].
    Khar'kovskaia NA; Klepikov NN; Shurygina TN; Khrusta SA
    Eksp Onkol; 1988; 10(1):55-8. PubMed ID: 3371248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficiencies of experimental designs for an illness-death model.
    Borgan O; Liestøl K; Ebbesen P
    Biometrics; 1984 Sep; 40(3):627-38. PubMed ID: 6518242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re-examination of the ED01 study--risk assessment using time.
    Fundam Appl Toxicol; 1981; 1(1):88-123. PubMed ID: 7184778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A stochastic model for censored-survival data in the presence of an auxiliary variable.
    Lagakos SW
    Biometrics; 1976 Sep; 32(3):551-9. PubMed ID: 963170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Threshold parameters for a simple stochastic partnership model of sexually transmitted diseases formulated as a two-type CMJ process.
    Mode CJ
    IMA J Math Appl Med Biol; 1997 Dec; 14(4):251-60. PubMed ID: 9415994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-specific models of mortality and tumor onset for historical control animals in the National Toxicology Program's carcinogenicity experiments.
    Portier CJ; Hedges JC; Hoel DG
    Cancer Res; 1986 Sep; 46(9):4372-8. PubMed ID: 3731095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of heterozygosity occurs via mitotic recombination in Trp53+/- mice and associates with mammary tumor susceptibility of the BALB/c strain.
    Blackburn AC; McLary SC; Naeem R; Luszcz J; Stockton DW; Donehower LA; Mohammed M; Mailhes JB; Soferr T; Naber SP; Otis CN; Jerry DJ
    Cancer Res; 2004 Aug; 64(15):5140-7. PubMed ID: 15289317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The parasite capacity of the host population].
    Kozminskiĭ EV
    Parazitologiia; 2002; 36(1):48-59. PubMed ID: 11965643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonparametric estimation of lifetime and disease onset distributions from incomplete observations.
    Dinse GE; Lagakos SW
    Biometrics; 1982 Dec; 38(4):921-32. PubMed ID: 7168795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinogenic properties of dicarboxydine (gamma,gamma'-3,3'-benzidine dioxydibutyric acid).
    Pliss GB; Volfson NI
    Arch Geschwulstforsch; 1979; 49(3):229-39. PubMed ID: 496563
    [No Abstract]   [Full Text] [Related]  

  • 20. The influence of sex, dose, time, and cross on neoplasia in mice given benzidine dihydrochloride.
    Nelson CJ; Baetcke KP; Frith CH; Kodell RL; Schieferstein G
    Toxicol Appl Pharmacol; 1982 Jun; 64(2):171-86. PubMed ID: 7123548
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.